The Structural and Dynamic Response of MAGI-1 PDZ1 with Noncanonical Domain Boundaries to the Binding of Human Papillomavirus E6

https://doi.org/10.1016/j.jmb.2011.01.015Get rights and content

Abstract

PDZ domains are protein interaction domains that are found in cytoplasmic proteins involved in signaling pathways and subcellular transport. Their roles in the control of cell growth, cell polarity, and cell adhesion in response to cell contact render this family of proteins targets during the development of cancer. Targeting of these network hubs by the oncoprotein E6 of “high-risk” human papillomaviruses (HPVs) serves to effect the efficient disruption of cellular processes. Using NMR, we have solved the three-dimensional solution structure of an extended construct of the second PDZ domain of MAGI-1 (MAGI-1 PDZ1) alone and bound to a peptide derived from the C-terminus of HPV16 E6, and we have characterized the changes in backbone dynamics and hydrogen bonding that occur upon binding. The binding event induces quenching of high-frequency motions in the C-terminal tail of the PDZ domain, which contacts the peptide upstream of the canonical X-[T/S]-X-[L/V] binding motif. Mutations designed in the C-terminal flanking region of the PDZ domain resulted in a significant decrease in binding affinity for E6 peptides. This detailed analysis supports the notion of a global response of the PDZ domain to the binding event, with effects propagated to distal sites, and reveals unexpected roles for the sequences flanking the canonical PDZ domain boundaries.

Graphical Abstract

Research Highlights

► The solution structure of the second PDZ domain of the MAGI-1 protein has been solved both in its free form and in complex with a peptide from the E6 HPV oncoprotein. ► Peptide binding leads to a disorder-to-order transition at the C-terminal part of the PDZ domain. ► Mutagenesis of the C-terminal extension (outside the canonical PDZ domain boundaries) leads to a decrease in affinity for the E6 peptide.

Introduction

PDZ domains are protein–protein interaction domains that are commonly found in cytoplasmic proteins involved in signaling pathways or subcellular transport.1, 2, 3 PDZ domains play roles in localizing proteins to the membrane and in acting as molecular scaffoldings or adaptors, but also serve in other functions such as binding to titin Z-repeats in the Z-disk of sarcomeres4 or detecting unfolded proteins and activating proteases.5 Many PDZ-domain-containing proteins are located at the interface between the cytoskeleton and the cellular membrane, where they are implicated in the formation of cellular junctions such as synapses,6 adherens junctions, or tight junctions.7 They commonly form multiprotein complexes at the inner interface of the membrane and are associated with the control of cell growth, cell polarity, and cell adhesion in response to cell contact and thus represent a family of proteins targeted during the development of cancer.8 Multiple PDZ domains are often found within a single protein connected by linkers of varying lengths, and found to be associated with other domains such as WW and SH3 domains, reflecting multiple functions. This further suggests that the composite protein function may be more than the sum of individual domains.

Viral proteins often target PDZ domains, resulting in the disruption of cellular processes for the benefit of the viral life cycle. The targeting of PDZ-domain-containing proteins involved in cellular adhesion and control of polarity has been shown to be a highly important activity in the process of cancer development following infection by “high-risk” human papillomaviruses (HPVs).9, 10, 11 The expression of two HPV oncoproteins, E6 and E7, that cooperate in cell immortalization and transformation has been associated with tumorigenesis.12, 13 E6 has a number of distinct functions in the host cell. It targets the tumor suppressor p53 for degradation through the formation of a trimeric complex with the cellular ubiquitin ligase E6AP14 and represses p53-dependent cell-cycle control and p53-dependent transcription by inhibiting p300-mediated acetylation.15 In addition, E6 binds and sometimes drives the proteasome-mediated degradation (via PDZ domain recognition) of several PDZ-domain-containing proteins. These include various MAGUKs (membrane-associated guanylate kinases), such as Dlg-116, Dlg-4,17 and hScrib,18 and MAGI (membrane-associated guanylate kinase with inverted domains) proteins, such as MAGI-119, MAGI-2, and MAGI-320 (Fig. 1a). The tumorigenic effects of HPV E6 depend partly on interfering with MAGI-1 functions in the living cell.19 Several non-MAGUK proteins such as CAL,21 MUPP-122, PATJ,23 PTPN3,24 Tip1,25 and Tip226 are also targeted by E6. The interaction of high-risk HPV E6 proteins with PDZ domains is mediated by C-terminal peptide sequences matching the X-[T/S]-X-[L/V] motif of “class I” PDZ domains27, 28, 29 and is associated with the development of cervical cancer.29, 30 This consensus sequence is only found in high-risk HPV E6s (such as HPV16 or HPV18) that differ in their C-terminal residues and, as a result, exhibit different affinities for MAGI-1.8, 31, 32 A higher affinity seems to correlate with an increased likelihood of recurrence and metastasis in cervical tumors.20, 33 This variability in the C-terminal residue of HPV E6 proteins has been suggested to be important in fine-tuning the affinities of the viral oncoproteins for distinct sets of PDZ domains.9

Understanding how the E6 viral protein interferes with the endogenous network of interactions mediated by PDZ domains requires both knowing the general rules governing PDZ–peptide interactions and deciphering the specific strategies used by the virus during infection. In the past few years, many studies attempted to characterize the ligand binding “specificity code” of PDZ domains. Initial analysis of peptide library screens, combined with sequence analysis to identify C-terminal consensus binding sequences, led to the definition of three major PDZ domain classes.2, 34 Later, the mapping of 3100 peptides identified by phage display against 82 PDZ domains from worms and humans allowed a more precise analysis of binding specificity and resulted in a classification of PDZ domains into 16 distinct specificity classes.35 A study of the binding selectivity of 157 PDZ domains from the mouse proteome using protein microarrays and quantitative fluorescence polarization36 showed that selectivity is derived from interactions throughout the binding pocket. This led the authors to suggest that, in terms of binding selectivity, PDZ domains constitute a continuum rather than discrete classes.

At the molecular level, a large number of three-dimensional structures of PDZ domains have been determined,37 with a number of them being available in both unliganded and liganded forms, allowing structural changes induced by peptide binding to be studied. In most cases, the structure of PDZ domains displayed a very small change upon peptide binding.38, 39 However, from a dynamic point of view, computational40, 41, 42, 43, 44, 45 approaches have highlighted the role of regions distal to the peptide binding site in forming dynamic networks within PDZ domains, and a number of studies have characterized changes in dynamics using NMR, thus providing experimental evidence for these networks.39, 46, 47, 48

Initial structural insight into the targeting of PDZ domains by HPV E6 protein was provided by the crystal structures of a short peptide from HPV18 E6 bound to three PDZ domains from MAGI-1 and SAP97/Dlg.49 This work revealed that peptide residues outside the canonical PDZ binding motif were involved in direct contacts with the canonical core regions of the PDZ domains. In addition, constructs of MAGI-1 PDZ1 [the second of the six PDZ domains in the sequence of human MAGI-1; residues 456–580 of human MAGI-1 (GenBank accession no. AF401656) when referring to the specific polypeptide used in these studies] were seen to form covalent cysteine-bridged dimers both in solution and in the crystal.

Recently, the extension of domain boundaries for the PDZ1 domain of MAGI-1 enabled us to study its properties in solution by NMR.50, 51 Using NMR, we solved the three-dimensional solution structures of MAGI-1 PDZ1 both unliganded and bound to a peptide derived from the C-terminus of HPV16 E6. In contrast to the crystal structure, we found that the domain was monomeric in both apo and holo forms. Furthermore, we found that peptide binding induced important changes in backbone dynamics and hydrogen bonding. While supporting the notion of a global response of the PDZ domain to the binding event, our study revealed an unexpected contribution to the binding process by sequences flanking the canonical PDZ domain boundaries.

Section snippets

Changes in chemical shift upon E6 peptide binding

Initial studies with C-terminal peptides from HPV16 E6 showed that peptides representing the 11 C-terminal amino acids fully reproduced the spectral changes observed when using the C-terminal domain of HPV16 E6, while shorter C-terminal peptides did not,50 suggesting the involvement of residues outside the canonical binding motif. Similar observations have been made in other studies.34, 52, 53, 54 We previously showed that the mutation of the C-terminal leucine residue into a valine resulted in

Discussion

PDZ domains represent one of the largest families of protein–protein recognition domains. As such, in recent years, they have attracted considerable interest in studies aimed at deciphering recognition specificity mechanisms at the molecular level. Our study of the MAGI-1 PDZ1 domain addresses the specific case of an interaction between a PDZ domain and the HPV E6 viral protein that targets several PDZ domains during the infection phase.19, 58 By comparing NMR measurements on liganded and

NMR experiments

Samples of unlabeled, 15N-labeled, and 15N,13C-labeled MAGI-1 PDZ1 were prepared in 20 mM or 100 mM phosphate buffer (pH 6.8) with 50 mM NaCl and 2 mM DTT, at protein concentrations between 200 μM and 600 μM. The MAGI-1 PDZ1/16E6ct L0/V complex was prepared by addition of a 3-fold excess of the synthesized 11-mer 16E6ct L0/V peptide.

NMR experiments were performed (unless otherwise stated) on a Bruker DRX 600-MHz spectrometer equipped with a triple-resonance cryoprobe with z-gradients at 295 K.

Acknowledgements

The authors thank Claude Ling (Institut de Génétique et de Biologie Moléculaire et Cellulaire) for technical support and Pascal Eberling (Institut de Génétique et de Biologie Moléculaire et Cellulaire) for peptide synthesis. The authors thank the European NMR Large-Scale Facility Utrecht and Dr. E. Guittet (ICSN, Gif-sur-Yvette, CNRS TGE NMR program) for access to high-field NMR spectrometers, and Dr. T. Herrmann (ENS, Lyon) for advice on the use of software. This work was supported by ANR

References (79)

  • GianniS. et al.

    Demonstration of long-range interactions in a PDZ domain by NMR, kinetics, and protein engineering

    Structure

    (2006)
  • FuentesE.J. et al.

    Evaluation of energetic and dynamic coupling networks in a PDZ domain protein

    J. Mol. Biol.

    (2006)
  • CharbonnierS. et al.

    Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies

    Protein Expression Purif.

    (2008)
  • ZhangJ. et al.

    Structural basis of beta-catenin recognition by Tax-interacting protein-1

    J. Mol. Biol.

    (2008)
  • TochioH. et al.

    Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95

    J. Mol. Biol.

    (2000)
  • KozlovG. et al.

    Solution structure of the PDZ2 domain from cytosolic human phosphatase hPTP1E complexed with a peptide reveals contribution of the beta2–beta3 loop to PDZ domain–ligand interactions

    J. Mol. Biol.

    (2002)
  • ThomasM. et al.

    Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates

    Virology

    (2008)
  • LongJ. et al.

    Supramodular nature of GRIP1 revealed by the structure of its PDZ12 tandem in complex with the carboxyl tail of Fras1

    J. Mol. Biol.

    (2008)
  • LongJ.F. et al.

    Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95

    J. Mol. Biol.

    (2003)
  • KangB.S. et al.

    PDZ tandem of human syntenin: crystal structure and functional properties

    Structure

    (2003)
  • van IngenH. et al.

    Structural insight into the recognition of the H3K4me3 mark by the TFIID subunit TAF3

    Structure

    (2008)
  • HerrmannT. et al.

    Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA

    J. Mol. Biol.

    (2002)
  • SchwietersC.D. et al.

    The Xplor-NIH NMR molecular structure determination package

    J. Magn. Reson.

    (2003)
  • KayL.E. et al.

    Pulse sequence for removal of the effects of cross-correlation between dipolar and chemical-shift anisotropy relaxation mechanims on the measurement of heteronuclear T1 and T2 values in proteins

    J. Magn. Reson.

    (1992)
  • SchultzJ. et al.

    Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels

    Nat. Struct. Biol.

    (1998)
  • JelenF. et al.

    PDZ domains—common players in the cell signaling

    Acta Biochim. Pol.

    (2003)
  • ThomasM. et al.

    Human papillomaviruses, cervical cancer and cell polarity

    Oncogene

    (2008)
  • JamesM.A. et al.

    Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner

    J. Virol.

    (2006)
  • ShaiA. et al.

    The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities

    Cancer Res.

    (2007)
  • GangulyN. et al.

    Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis

    J. Biosci.

    (2009)
  • HuibregtseJ.M. et al.

    A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18

    EMBO J.

    (1991)
  • PatelD. et al.

    The E6 protein of human papillomavirus type 16 binds to and inhibits co-actiation by CBP and p300

    EMBO J.

    (1999)
  • GrmH.S. et al.

    Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent

    J. Gen. Virol.

    (2004)
  • HandaK. et al.

    E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein

    J. Virol.

    (2007)
  • NakagawaS. et al.

    Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin–protein ligase

    Mol. Cell. Biol.

    (2000)
  • GlaunsingerB.A. et al.

    Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

    Oncogene

    (2000)
  • ThomasM. et al.

    Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

    Oncogene

    (2002)
  • JeongK.W. et al.

    Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation

    Oncogene

    (2007)
  • LeeS.S. et al.

    Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins

    J. Virol.

    (2000)
  • Cited by (43)

    • Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition

      2019, International Review of Cell and Molecular Biology
    • Peptide-Protein Binding Investigated by Far-IR Spectroscopy and Molecular Dynamics Simulations

      2017, Biophysical Journal
      Citation Excerpt :

      The experiments showed that upon peptide binding, the lowest frequency peak undergoes a red shift suggesting a softening of the vibrational mode. This is due to an increased number of hydrogen bonds in the ligand-bound complex, which was observed in the previous NMR experiments (19) and further confirmed by the molecular dynamics simulations presented here. To further understand this shift, the far-IR spectrum was analyzed through computational analysis of the same constructs used in the experiments.

    View all citing articles on Scopus
    View full text